Bacil Pharma Ltd.

Financial

	Bacil Pharma	Concord Drugs	Lasa Supergenerics
Operational Metrics
Financials
5 yr Average ROE	-73.86 %	3.38 %	-8.32 %
5yr average Equity Multiplier	1.72	1.86	1.44
5yr Average Asset Turnover Ratio	0.0	0.9	0.77
5yr Avg Net Profit Margin	0.0	1.88 %	-8.22 %
Price to Book	2.12	1.64	0.61
P/E	133.51	166.67	0.0
5yr Avg Cash Conversion Cycle	0.0	260.53 Days	11.27 Days
Inventory Days	0.0	138.17 Days	46.83 Days
Days Receivable	0.0	144.77 Days	10.61 Days
Days Payable	23.71 Days	77.93 Days	83.41 Days
5yr Average Interest Coverage Ratio	-950.16	1.8	-18.91
5yr Avg ROCE	-81.01 %	8.9 %	1.03 %
5yr Avg Operating Profit Margin	0.0	9.09 %	9.99 %
5 yr average Debt to Equity	0.08	0.55	0.2
5yr CAGR Net Profit	-28.45 %	-21.63 %	n/a
5yr Average Return on Assets	-72.13 %	1.77 %	-5.59 %
Shareholdings
Promoter Holding	0.2 %	54.39 %	53.65 %
Share Pledged by Promoters	0.0	0.0	20.66 %
Change in Promoter Holding (3 Yrs)	-42.47 %	5.39 %	9.87 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0